Analyzing Basel Medical Group (NASDAQ:BMGL) & Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health (NYSE:HIMS) and Basel Medical Group (NASDAQ:BMGL) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Hims & Hers Health and Basel Medical Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1	11	4	0	2.19
Basel Medical Group	1	0	0	0	1.00

Hims & Hers Health presently has a consensus target price of $32.50, suggesting a potential upside of 11.49%. Given Hims & Hers Health’s stronger consensus rating and higher probable upside, equities analysts clearly believe Hims & Hers Health is more favorable than Basel Medical Group.

Profitability

This table compares Hims & Hers Health and Basel Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Basel Medical Group	N/A	N/A	N/A

Insider & Institutional Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Hims & Hers Health has a beta of 2.4, meaning that its stock price is 140% more volatile than the S&P 500. Comparatively, Basel Medical Group has a beta of 0.24, meaning that its stock price is 76% less volatile than the S&P 500.

Valuation and Earnings

This table compares Hims & Hers Health and Basel Medical Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35 billion	2.90	$128.37 million	($0.63)	-46.27
Basel Medical Group	$14.55 million	0.57	-$9.50 million	N/A	N/A

Hims & Hers Health has higher revenue and earnings than Basel Medical Group.

Summary

Hims & Hers Health beats Basel Medical Group on 9 of the 12 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.